![Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40618-018-0991-0/MediaObjects/40618_2018_991_Fig1_HTML.png)
Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink
![Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram](https://www.researchgate.net/profile/Iqbal-Malik/publication/23304097/figure/fig2/AS:310188415438849@1450966089391/Mechanism-of-action-of-sitagliptin-vildagliptin-and-exenatide-GLP-1-is-released-from-L.png)
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
![Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing](https://w7.pngwing.com/pngs/475/613/png-transparent-dipeptidyl-peptidase-4-inhibitor-glucagon-like-peptide-1-receptor-agonist-liraglutide-dulaglutide-others-angle-text-pharmaceutical-drug.png)
Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig1_HTML.png)
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
![The incretin hormone GLP‐1 and mechanisms underlying its secretion - Tian - 2016 - Journal of Diabetes - Wiley Online Library The incretin hormone GLP‐1 and mechanisms underlying its secretion - Tian - 2016 - Journal of Diabetes - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ba41cf6e-4ccf-4587-8bea-2c4f2127d23a/jdb12439-fig-0002-m.jpg)
The incretin hormone GLP‐1 and mechanisms underlying its secretion - Tian - 2016 - Journal of Diabetes - Wiley Online Library
![Sitagliptin Compared with Thiazolidinediones as a Third-Line Oral Antihyperglycemic Agent in Type 2 Diabetes Mellitus - Endocrine Practice Sitagliptin Compared with Thiazolidinediones as a Third-Line Oral Antihyperglycemic Agent in Type 2 Diabetes Mellitus - Endocrine Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/c2beda9e-d469-49a6-a4e6-624d0138e045/gr1.jpg)
Sitagliptin Compared with Thiazolidinediones as a Third-Line Oral Antihyperglycemic Agent in Type 2 Diabetes Mellitus - Endocrine Practice
![IJMS | Free Full-Text | Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model | HTML IJMS | Free Full-Text | Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model | HTML](https://www.mdpi.com/ijms/ijms-19-03226/article_deploy/html/images/ijms-19-03226-g011-550.jpg)
IJMS | Free Full-Text | Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model | HTML
![Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9268d3a9-5c5a-4d5a-9315-192ffb3aa9b5/cam43024-fig-0006-m.jpg)
Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig2_HTML.png)